Want to join the conversation?
$CI 2Q15 PR: Consolidated revenues were $9.5Bil, an increase of 9% over 2Q14 primarily driven by continued growth in Cigna's targeted customer segments. Shareholders’ net income was $588MM, or $2.26 per share, vs. $573MM, or $2.12 per share, for 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?